5.305
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché SANA Giù?
Forum
Previsione
Precedente Chiudi:
$5.92
Aprire:
$6.06
Volume 24 ore:
14.74M
Relative Volume:
2.79
Capitalizzazione di mercato:
$1.26B
Reddito:
-
Utile/perdita netta:
$-252.18M
Rapporto P/E:
-5.0047
EPS:
-1.06
Flusso di cassa netto:
$-185.29M
1 W Prestazione:
+19.21%
1M Prestazione:
+71.13%
6M Prestazione:
+235.76%
1 anno Prestazione:
+25.41%
Sana Biotechnology Inc Stock (SANA) Company Profile
Nome
Sana Biotechnology Inc
Settore
Industria
Telefono
(206) 701-7914
Indirizzo
188 EAST BLAINE STREET, SUITE 400, SEATTLE
Confronta SANA con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
SANA
Sana Biotechnology Inc
|
5.305 | 1.14B | 0 | -252.18M | -185.29M | -1.06 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
![]()
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
![]()
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Sana Biotechnology Inc Stock (SANA) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-09-24 | Iniziato | Wedbush | Outperform |
2025-07-03 | Ripresa | Morgan Stanley | Overweight |
2025-03-18 | Aggiornamento | Citizens JMP | Mkt Perform → Mkt Outperform |
2025-03-14 | Iniziato | Jefferies | Buy |
2025-01-08 | Aggiornamento | TD Cowen | Hold → Buy |
2024-11-05 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
2024-06-26 | Iniziato | Rodman & Renshaw | Buy |
2024-01-16 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
2023-09-25 | Iniziato | JMP Securities | Mkt Outperform |
2023-09-05 | Iniziato | Citigroup | Buy |
2023-08-14 | Iniziato | TD Cowen | Market Perform |
2023-05-02 | Iniziato | H.C. Wainwright | Neutral |
2021-03-01 | Iniziato | BofA Securities | Buy |
2021-03-01 | Iniziato | Goldman | Neutral |
2021-03-01 | Iniziato | JP Morgan | Neutral |
2021-03-01 | Iniziato | Morgan Stanley | Overweight |
Mostra tutto
Sana Biotechnology Inc Borsa (SANA) Ultime notizie
Sana Biotechnology: Scope Goes Beyond HIP-Modified Pancreatic Islet Cells For T1D - Seeking Alpha
Sana Biotechnology: A Big Winner In Waiting? Maybe, But It Won't Happen Overnight (SANA) - Seeking Alpha
Sana Biotechnology (SANA) Stock Skyrockets on ‘100-Bagger’ Hype – Experts Debate What’s Next - ts2.tech
Exclusive BAC Article: Sana Biotechnology; Positive 6-Month Initial POC Type 1 Diabetes Data UP421, Additional Results 2nd Half 2025, SC291 And SC262 Data 2025 And Catalysts (NASDAQ:SANA) - Seeking Alpha
Sana Biotech Shares Skyrocket on 100x Hype – What’s Behind the Rally? - ts2.tech
Sana Biotech Stock — The Next '100-Bagger'? - Benzinga
Using Ichimoku Cloud for Sana Biotechnology Inc. technicalsQuarterly Trade Summary & Daily Entry Point Alerts - newser.com
Sana Biotechnology stock higher after Eric Jackson touts 100-bagger potential - Yahoo Finance
Sana Biotech surges as Eric Jackson calls it a 100-bagger - MSN
Sana Biotech surges after Eric Jackson post (SANA:NASDAQ) - Seeking Alpha
Will Sana Biotechnology Inc. stock maintain momentum in 2025Portfolio Growth Summary & Fast Gaining Stock Reports - newser.com
Real time alert setup for Sana Biotechnology Inc. performance2025 Key Highlights & Detailed Earnings Play Strategies - newser.com
Will Sana Biotechnology Inc. stock outperform tech sector in 2025July 2025 Weekly Recap & Reliable Intraday Trade Plans - newser.com
Real time breakdown of Sana Biotechnology Inc. stock performanceJuly 2025 Setups & Risk Managed Investment Signals - newser.com
Comparing Sana Biotechnology Inc. in custom built stock radars2025 Market WrapUp & Daily Profit Maximizing Trade Tips - newser.com
Is Sana Biotechnology Inc. a candidate for recovery playQuarterly Portfolio Review & Proven Capital Preservation Methods - newser.com
How to escape a deep drawdown in Sana Biotechnology Inc.July 2025 Levels & Expert Verified Movement Alerts - newser.com
Visualizing Sana Biotechnology Inc. stock with heatmapsQuarterly Profit Report & Technical Entry and Exit Tips - newser.com
Sana Biotechnology (SANA): Evaluating Valuation Following Recent 47% Share Price Surge - Yahoo Finance
Sana Biotechnology's (SANA) Sell (E+) Rating Reaffirmed at Weiss Ratings - MarketBeat
How to build a dashboard for Sana Biotechnology Inc. stockGold Moves & Risk Controlled Stock Alerts - newser.com
Statistical indicators supporting Sana Biotechnology Inc.’s strength2025 Year in Review & Stock Portfolio Risk Control - newser.com
Evaluating Sana Biotechnology (SANA): Is Recent Momentum Reflected in Its Current Valuation? - Sahm
Sana Biotechnology (NASDAQ:SANA) Trading 9.1% HigherShould You Buy? - MarketBeat
Is a relief rally coming for Sana Biotechnology Inc. holdersTreasury Yields & AI Powered Market Entry Ideas - newser.com
Visual analytics tools that track Sana Biotechnology Inc. performanceJuly 2025 Update & Accurate Technical Buy Alerts - newser.com
Combining price and volume data for Sana Biotechnology Inc.2025 Support & Resistance & Long-Term Safe Return Strategies - newser.com
Does Sana Biotechnology Inc. show high probability of reboundJuly 2025 Macro Moves & Free Expert Verified Stock Movement Alerts - newser.com
What data driven models say about Sana Biotechnology Inc.’s futureNew Guidance & Verified Momentum Stock Watchlist - newser.com
Certain Stock Options of Sana Biotechnology, Inc. are subject to a Lock-Up Agreement Ending on 6-OCT-2025. - MarketScreener
Certain Restricted Stock Units of Sana Biotechnology, Inc. are subject to a Lock-Up Agreement Ending on 6-OCT-2025. - MarketScreener
Sector ETF performance correlation with Sana Biotechnology Inc.Bear Alert & Verified Trade Idea Suggestions - newser.com
Certain Common Stock of Sana Biotechnology, Inc. are subject to a Lock-Up Agreement Ending on 6-OCT-2025. - MarketScreener
Sana Biotechnology, Inc. (NASDAQ:SANA) Receives $7.50 Consensus Price Target from Brokerages - Defense World
Sana Biotechnology Inc Azioni (SANA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Sana Biotechnology Inc Azioni (SANA) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
Cassidy Bernard J | EVP & General Counsel |
Mar 07 '25 |
Option Exercise |
0.00 |
11,041 |
0 |
115,823 |
Harr Steve | President & CEO |
Mar 07 '25 |
Option Exercise |
0.00 |
50,000 |
0 |
7,889,750 |
Wyrick Susan D. | See Remarks |
Mar 02 '25 |
Option Exercise |
0.00 |
1,525 |
0 |
155,471 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):